Showing results (1-10 of 210) with videos related to
Sort By:
Pageof 21
STAR Protocols|November 30, 2023
Protocol for cell-based screening assay to measure ERK1/2 phosphorylation as a readout for complement receptor activationXaria X Li, Trent M WoodruffPharmacological Reviews|July 19, 2025
The complement system: Biology, pathology, and therapeutic interventionsXaria X Li, Trent M WoodruffJournal of Immunology (Baltimore, Md. : 1950)|July 3, 2020
C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human MacrophagesXaria X Li, Richard J Clark, Trent M WoodruffInternational Immunopharmacology|August 28, 2021
Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonistsXaria X Li, Richard J Clark, Trent M WoodruffJournal of Immunology (Baltimore, Md. : 1950)|June 5, 2019
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive ImmunityXaria X Li, John D Lee, Claudia Kemper, et al.Trends in Biochemical Sciences|May 14, 2020
Emerging Insights into the Structure and Function of Complement C5a ReceptorsShubhi Pandey, Jagannath Maharana, Xaria X Li, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
Cell-intrinsic C5a synergizes with Dectin-1 in macrophages to mediate fungal killingXaria X Li, Jenny N Fung, Richard J Clark, et al.Frontiers in Pharmacology|February 8, 2021
The "C3aR Antagonist" SB290157 is a Partial C5aR2 AgonistXaria X Li, Vinod Kumar, Richard J Clark, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2021
Unexpected Off-Target Activities for Recombinant C5a in Human MacrophagesXaria X Li, Declan M Gorman, John D Lee, et al.Molecular Immunology|June 4, 2017
New concepts on the therapeutic control of complement anaphylatoxin receptorsOwen A Hawksworth, Xaria X Li, Liam G Coulthard, et al.Pageof 21